2006
Halbur PG, Opriessnig T. The building blocks of PCV2-associated diseases: Co-factors, host susceptibility, strain characterization and immune modulation. In: PCV2/PMWS seminar#7: Understanding factors that impact disease expression and control. 31-38. 37th AASV, Kansas City, Missouri, March 2006.
Halbur PG, Opriessnig T. Practical management of PCV2-associated disease: The American experience. In: PCV2/PMWS seminar#7: Understanding factors that impact disease expression and control. 65-71. 37th AASV, Kansas City, Missouri, March 2006.
Opriessnig T, Zhou EM, Yoon KJ, Halbur PG. Effectively using diagnostic tools for PCV2-asscociated diseases. In: PCV2/PMWS seminar#7: Understanding factors that impact disease expression and control. 9-19. 37th AASV, Kansas City, Missouri, March 2006.
Opriessnig T, McKeown NE, Meng XJ, Halbur PG. Comparison of pathogenicity of US PCV2 field isolates in an experimental pigs model. Proc 37th AASV, Kansas City, Missouri, 37:451-452, March 2006.
Opriessnig T, Halbur PG. Porcine circovirus type 2 (PCV2)-infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine. Proc 37th AASV, Kansas City, Missouri, 37:453-454, March 2006.
Opriessnig T, Lunney KJ, Thacker E, Halbur PG. Comparison of cytokine profiles in pigs singularly or coinfected with PCV2, or Mycoplasma hyopneumoniae. 10-11. 45th Annual Meeting North Central Conference of Veterinary Laboratory Diagnosticians, Lincoln, Nebraska, June 8-9, 2006.
Opriessnig T, Halbur PG. Transmission of PCV2 through consumption of pork products from pigs experimentally infected with PCV2. 12-13. 45th Annual Meeting North Central Conference of Veterinary Laboratory Diagnosticians, Lincoln, Nebraska, June 8-9, 2006.
Opriessnig T, Yoon K-J, Russell L, Halbur PG. No Evidence of infectivity of PCV2 nucleic acids present in spray-dried plasma protein. 14-15. 45th Annual Meeting North Central Conference of Veterinary Laboratory Diagnosticians, Lincoln, Nebraska, June 8-9, 2006.
Opriessnig T, Thomas P, Meng XJ, McKeown NE, Halbur PG. Comparison of the efficacy of three different serotherapy regimens and vaccination with a chimeric PCV1-2 vaccine to protect pigs against PCV2 infection and disease. Volume 1:160. 19th International Pig Veterinary Society Congress, Copenhagen, Denmark, July 16-19, 2006.
Opriessnig T, Halbur PG. Transmission of PCV2 through consumption of meat or other products from pigs experimentally infected with PCV2. Volume 1:164. 19th International Pig Veterinary Society Congress, Copenhagen, Denmark, July 16-19, 2006.
Opriessnig T, Lunney KJ, Kuhar D, Thacker E, Halbur PG. Comparison of cytokine profiles in pigs singularly or coinfected with PCV2, or Mycoplasma hyopneumoniae. Volume 1:170. 19th International Pig Veterinary Society Congress, Copenhagen, Denmark, July 16-19, 2006.
McKeown NE, Opriessnig T, Fenaux M, Elvinger F, Halbur PG, Meng XJ. Assessment of the role of two mutations in the capsid protein of type 2 porcine circovirus in PCV2 virulence. Volume 1:166. 19th International Pig Veterinary Society Congress, Copenhagen, Denmark, July 16-19, 2006.
Opriessnig T, McKeown NE, Meng XJ, Halbur PG. Experimental confirmation that PCV2 isolates differ in virulence. Volume 1:167. 19th International Pig Veterinary Society Congress, Copenhagen, Denmark, July 16-19, 2006.
Opriessnig T, Halbur PG. Efficacy of planned exposure to protect pigs against porcine reproductive and respiratory syndrome virus challenge. Volume 1:233. 19th International Pig Veterinary Society Congress, Copenhagen, Denmark, July 16-19, 2006.
Halbur PG, Rapp-Gabrielson V, Hoover T, Sornsen S, Yu S, Opriessnig T, Strait E, Kesl L, Taylor L, Jolie R, Thacker E. Evaluation of Mycoplasma hyopneumoniae vaccination in a M. hyopneumoniae/porcine circovirus type 2 coinfection model. Volume 1:271. 19th International Pig Veterinary Society Congress, Copenhagen, Denmark, July 16-19, 2006.
Opriessnig T, Halbur PG. Recent advances in research related to porcine circovirus type 2. 47: 1-10. The 47th Annual George A. Young Swine Health and Management Conference, August 17, 2006.
2005
Opriessnig T, Thomas P, McKeown N, Meng X-J, Engle M, Halbur PG. Genomic and in vivo comparison of PCV2 isolates from clinical PMWS cases with and without hallmark lesions of lymphoid depletion. Proc 36th AASV, Toronto, Canada 36:387-389, March 2005.
Thomas P, Opriessnig T, McKeown N, Meng X-J, Halbur P. Effect of PCV2 passive antibody levels on immunization with chimeric PCV1-2 vaccine and challenge with wild type PCV2. Proc 36th AASV, Toronto, Canada 36:23-25, March 2005.
Opriessnig T, Rothschild MF, Halbur PG. Differences among pig breeds in susceptibility to porcine circovirus type 2-associated disease. Proc 3rd Intern Symposium on Genetics of Animal Health, Ames, Iowa. Abstract p. 105, July 13-15, 2005.
Opriessnig T, Halbur PG. Influence of porcine circovirus type 2 (PCV2)-infection on efficacy and safety of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine. Proc Intern Conf “Animal Circoviruses and Associated Diseases”, European Society for Veterinary Virology, Belfast, Northern Ireland, Abstract p 34, Sept 11-13, 2005.
Halbur P, Opriessnig T, Thomas P. Best practices for control of PCV2-associated diseases. 13th Swine Disease Conf Swine Pract,Ames, Iowa.13:98-107, November 10-11, 2005.
Opriessnig T., Halbur PG. Porcine circovirus type 2 (PCV2)-infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome (PRRSV) vaccine. Proc. AAVLD, Hershey Pennsylvania, 48:107, Nov 3-7, 2005.
Opriessnig T., Halbur PG. Comparison of the pathogenicity of US PCV2 isolates from cases with and without the hallmark PCV2-associated lymphoid lesions. Proc. AAVLD, Hershey, Pennsylvania, 48:106, Nov 3-7, 2005.
2004
Fenaux M, Opriessnig T, Halbur PG, Meng XJ. Development of a genetically-engineered vaccine against type 2 porcine circovirus. Proc. 18th IPVS, Hamburg, Germany, p 20, 2004.
Fenaux M, Opriessnig T, Halbur PG, Xu Y, Potts B, Meng XJ. Detection and in vitro and in vivo characterization of porcine circoviruses in porcine-derived commercial pepsin products. Proc. 18th IPVS, Hamburg, Germany, p 19, 2004.
Hoogland M, Opriessnig T, Meng XJ, Halbur PG. Effect of commonly used bacterin adjuvants on PCV2-associated lesions. Proc. 18th IPVS, Hamburg, Germany, abstract #761, 2004.
Opriessnig T, Meng XJ, Halbur PG. Effect of timing of vaccination with a commercially available bacterin on PCV2-associated lesions. Proc. 18th IPVS, Hamburg, Germany, abstract #760, 2004.
Opriessnig T, Yu S, Meng XJ, Thacker EL, Halbur PG. PCV2 and Mycoplasma hyopneumoniae coinfection model. Proc. 18th IPVS, Hamburg, Germany, abstract #759, 2004.
Opriessnig T, Anderson MS, Rothschild MF, Evans RB, Fenaux M, Meng XJ. Halbur PG. Evaluation of differences in host susceptibility to PCV2-associated diseases. Proc. 18th IPVS, Hamburg, Germany, abstract #758, 2004.
Opriessnig T, Halbur PG. PCV2 and M. hyo. coinfection results in severe respiratory disease and PMWS and effect of timing of M. hyo. vaccination on PCV2 infection. Proc. 18th IPVS, Hamburg, Germany, Practitioner Line. p.12, 2004.
Halbur P, Opriessnig T. Update on porcine circovirus-associated diseases. 12th Swine Disease Conf Swine Pract,Ames, Iowa.12:12-23, November 11-12, 2004.
Fenaux M, Opriessnig T, Halbur PG, Elvinger F, Meng X-J. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of pathogenic PCV2 cloned into the genomic backbone of non-pathogenic PCV1 induces protective immunity against PCV2 infection in pigs. Proc 85th CRWAD,Chicago, Illinois. Abstract #206, p143, November, 2004.
Fenaux M, Opriessnig T, Halbur PG, Elvinger F, Meng X-J. Two amino acid mutations in the capsid protein of type 2 porcine circovirus (PCV2) enhanced PCV2 replication in vitro and attenuated the virus in vivo. Proc 85th CRWAD,Chicago, Illinois. Abstract #207, p143, November, 2004.
McKeown N, Opriessnig T, Thomas P, Guenette D, Fenaux M, Halbur P, Meng X-J. Effects of PCV2 maternal antibodies on immunization with PCV1-2 vaccine and infection with wild type PCV2. Proc 85th CRWAD, Chicago, Illinois. Abstract #205, p143, November, 2004.
Opriessnig T, Jones D, McKeown N, Meng X-J, Halbur PG. Development of a mouse model for PCV2-associated diseases. Proc 85th CRWAD,Chicago, Illinois. Abstract #208, p143, November, 2004.
Yu S, Vincent A, Opriessnig T, Carpenter S, Kitikoon P, Halbur P, Thacker E. In vitro studies on the use of quantitative real-time RT-PCR assay to detect PCV2 replication in peripheral blood mononuclear cells (PBMCs). Proc 85th CRWAD, Chicago, Illinois, Abstract #204, p142, November 2004.
Hoogland M, Opriessnig T, Halbur PG. Comparison of the effect of adjuvants on PCV2-associated diseases. Proc. 35th AASV, Des Moines, Iowa, pp 67-68, 2004.
Halbur PG, Opriessnig T. Immunology, pathogenesis, and control of PCV2-associated diseases. Proc. 35th AASV, Des Moines, Iowa, Seminar #3, Emerging disease, pp 27-38, 2004.
Halbur PG, Opriessnig T. What’s new at the diagnostic laboratory? Proc. 35th AASV, Des Moines, Iowa, Seminar #7, Skill and Tools for Practitioners, pp 21-28, 2004.
Opriessnig T, Halbur PG, Thacker EL, Yu S, Fenaux M, Meng XJ. Mycoplasma hyopneumoniae increases the severity and duration of PCV2-associated lung and lymphoid lesions. Proc. 35th AASV, Des Moines, Iowa, pp 441- 442, 2004.
2003
Opriessnig T, Halbur PG, Yu S, Thacker E, Fenaux M, Meng XJ. Effect of PPV-vaccination on the development of PMWS in PCV2 and PPV coinfected SPF pigs. Proc. 34th AASV, Orlando, Florida, pp 501-502, 2003.
Opriessnig T, Halbur PG. Update on diagnosis, pathogenesis, and control of PCV2-associated diseases in pigs in the U.S. Proc. Illinois Fall Veterinary Conf., 2003.
Halbur PG, Opriessnig T, Hoogland M, Thacker E, Yu S. PCV2-associated diseases: research and diagnostic update. Proc. 11th Swine Disease Conf Swine Pract, Ames, Iowa, pp 152-160, 2003.
Opriessnig T, Thacker EL, Yu S, Evans RB, Strait E, Vincent A, Halbur PG. A model for PCV2 and Mycoplasma hyopneumoniae induced porcine respiratory disease complex. Proc. 84th CRWAD, Chicago, Illinois, abstract #141, 2003.
Yu S, Carpenter S, Opriessnig T, Halbur PG, Thacker E. Development of an RT-PCR assay to detect porcine circovirus type 2 replication. Proc. 84th CRWAD, Chicago, Illinois, abstract #163, 2003.
2002
Opriessnig T, Halbur PG, Pallares F, Fenaux M, Meng XJ. Effect of age and vaccine induced immune stimulation on PCV2 infection. Proc. 17th IPVS, Ames, Iowa, p 203, 2002.
Yu S, Opriessnig T, Halbur PG, Meng XJ, Kitikoon P, Thacker B, Thomas P, Thacker E. Characterization of immune response to porcine circovirus type 2 infection. Proc. 17th IPVS, Ames, Iowa, p 404, 2002.
Halbur PG, Opriessnig T, Harding JC.Circovirus-associated disease: global literature review, pathogenesis and update, and control. Proc. 43th George Young Conf., Lincoln, Nebraska. pp 44-58, 2002.
Halbur PG, Opriessnig T. PCV2 associated diseases: pathognesis, diagnosis, and control. Proc. 88th Annual Meeting Interstate Veterinary Medical Association, Inc. South Sioux City, Nebraska, pp 68-78, 2002.
Halbur PG, Opriessnig T, Yu S, Thacker E. PMWS: laboratory experiences. Proc. 10th Swine Disease Conf Swine Pract, Ames, Iowa, pp 76-82, 2002.
Fenaux M, Opriessnig T, Halbur PG, Meng XJ. Immunogenicity and pathogenicity in pigs of chimeric infectious DNA clones between pathogenic type 2 porcine circoviru (PCV2) and non-pathogenic PCV1. Proc. 83th CRWAD, St. Louis, Missouri, abstract #176, 2002.
Opriessnig T, Halbur PG, Fenaux M, Yu S, Pallares FJ, Meng XJ. Effect of PPV-vaccination on the development of PMWS in PCV2 and PPV coinfected SPF pigs. Proc. 83th CRWAD, St. Louis, Missouri, abstract #177, 2002
Opriessnig T, Halbur PG, Yu S, Thacker E. Derivation of PCV2 negative pigs from positive sow herds. Proc. 83th CRWAD, St. Louis, Missouri, abstract #177, 2002.
Yu S, Opriessnig T, Halbur PG, Thacker E. In vitro studies on the infection of porcine lymphocytes with porcine circovirus 2. Proc. 83th CRWAD, St. Louis, Missouri, abstract #118, 2002.
Opriessnig T, Halbur PG, Pallares F, Evans R, Fenaux M, Meng XJ. Vaccine induced immune stimulation and PCV2-infection in conventional pigs. Proc. 45th AAVLD, St. Louis, Missouri, p 68, 2002.
NON-REFERRED PUBLICATIONS
Halbur PG, Opriessnig T. Vaccination and PCV2-associated diseases. Pig International 34:23-25, 2004.
Halbur PG, Opriessnig T. Pathogenese und Kontrolle von PCV2-assoziierten Krankheiten. Nutztierpraxis Aktuell 9:44-51, 2004.
Halbur PG, Opriessnig T. Management of PCV2-associated diseases in the U.S. Iowa Pork Producer 43, 4-5:28-29, 2006
